Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Tenofovir Alafenamide or Abacavir in HIV Patients with Tenofovir Disoproxil-Associated Renal Decline
2015-005045-31Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in human immunodeficiency virus infection (HIV) and chronic kidney disease (CKD) comparing TAF switch arm with Abacavir switch arm (2 arms). Started Feb 2016; status: active.
02
Drugs
tenofovir alafenamideabacavir
03
Conditions
human immunodeficiency virus infection (HIV)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2015-005045-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005045-31.